|
Contrast between day- and night-time effects of rosiglitazone on ambulatory BP at 12 months |
||
| Background metformin |
Background sulfonylurea |
|
|
|
||
| rosiglitazone vs sulfonylurea (difference (95% CI), p-value) |
rosiglitazone vs metformin (difference (95% CI), p-value) |
|
|
|
||
| Systolic BP (mmHg) |
||
| 24-hour |
-2.7 (-4.9, -0.5), 0.016 |
-2.5 (-4.8, -0.2), 0.031 |
| Day-time |
-3.3 (-5.6, -1.0), 0.004 |
-1.6 (-3.9, 0.9), NS |
| Night-time |
-1.5 (-3.9, 1.0), NS |
-4.0 (-6.6, -1.3), 0.004 |
| Diastolic BP (mmHg) |
||
| 24-hour |
-2.1 (-3.4, -0.7), 0.003 |
-3.1 (-4.5, -1.8), < 0.001 |
| Day-time |
-2.5 (-3.9, -1.0), 0.001 |
-2.5 (-3.9, -1.0), 0.001 |
| Night-time |
-1.3 (-2.9, 0.3), NS |
-4.0 (-5.7, -2.4), < 0.001 |
Komajda et al. Cardiovascular Diabetology 2008 7:10 doi:10.1186/1475-2840-7-10 |
||